
Mondove Biotech Private Limited
Develops and exports pharmaceutical products, including tablets, capsules, and syrups.
Develops and exports pharmaceutical products, including tablets, capsules, and syrups.
Mondove Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 April 2021 (Three years and ten months 19 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Gurnam Singh and Gurpreet Singh serve as directors at the Company.
Ambala, Haryana, India
+91-XXXXXXXXXX
-
U24100HR2021PTC094454
094454
Private Limited Indian Non-Government Company
14 Apr 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Mondove Biotech Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antifungal Cream, Ointment & Powder, Nutraceuticals & Dietary Supplements, Dietary Supplements, Ayurvedic,Herbal Products & Medicine.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gurnam Singh ![]() | Director | 14-Apr-2021 | Current |
Gurpreet Singh ![]() | Director | 20-Aug-2022 | Current |
Mondove Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 774.34% increase. The company also saw a substantial improvement in profitability, with a 129.34% increase in profit. The company's net worth Soared by an impressive increase of 122.62%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Mondove Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Gurnam Singh is a mutual person
₹10.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
13 Jun 2022 | Others | ₹1.00 Cr | Open |
Mondove Biotech has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mondove Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mondove Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mondove Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Others of Rs. 10.00 M registered on 13 Jun 2022 with Charge ID 100594375 was modified on 18 May 2024.
Mondove Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Gurpreet Singh was appointed as a Director was appointed as a Director on 20 Aug 2022 & has been associated with this company since 2 years 6 months .
A charge with Others amounted to Rs. 10.00 M with Charge ID 100594375 was registered on 13 Jun 2022.
Gurnam Singh was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 3 years 10 months .
Mondove Biotech Private Limited was incorporated on 14 Apr 2021.
The authorized share capital of Mondove Biotech Private Limited is ₹ 1.50 M and paid-up capital is ₹ 1.50 M.
Currently 2 directors are associated with Mondove Biotech Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mondove Biotech Private Limited is H No 98 Jaggi Colony City India, Ambala, Haryana, 134007.
The corporate identification number (CIN) of Mondove Biotech Private Limited is U24100HR2021PTC094454 and the company number is 094454 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Mondove Biotech Private Limited has risen by 774.34%.
The financial reports for the fiscal year 2023 indicates that The net worth of Mondove Biotech Private Limited has experienced an upsurge of 122.62%.
As per the financial statements for fiscal Year 2023, The total open charges for Mondove Biotech Private Limited amount to ₹ 1.00 Cr.
The most recent Balance Sheet for Mondove Biotech Private Limited was filed with the ROC on 31 Mar 2024.
MS